BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2025 6:40:47 AM | Browse: 92 | Download: 197
 |
Received |
|
2025-07-10 06:17 |
|
Peer-Review Started |
|
2025-07-10 06:17 |
|
First Decision by Editorial Office Director |
|
2025-07-17 10:14 |
|
Return for Revision |
|
2025-07-17 10:14 |
|
Revised |
|
2025-07-22 17:27 |
|
Publication Fee Transferred |
|
2025-07-23 21:44 |
|
Second Decision by Editor |
|
2025-10-27 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-27 05:40 |
|
Articles in Press |
|
2025-10-27 05:40 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-02 00:55 |
|
Publish the Manuscript Online |
|
2025-12-04 06:40 |
| ISSN |
1949-8454 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Review |
| Article Title |
Fatty liver reexamined choline and mitochondrial toxin amelioration
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Joseph Mercola |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph Mercola, Researcher, Independent Researcher, Midwestern University, 555 31st St, Downers Grove, IL 60515, United States. drm@mercola.com |
| Key Words |
Choline; Citicoline; Fatty liver disease; Linoleic acid; Mitochondrial dysfunction; Phosphatidylcholine; Phosphatidylethanolamine; Phospholipid metabolism; Dietary intervention; Hepatic steatosis |
| Core Tip |
This review recasts fatty liver disease as a reversible mitochondrial toxicosis driven by linoleic acid (LA) and ethanol when choline intake is inadequate. It collates pre-clinical and pilot clinical evidence showing that bioavailable, gut microbial trimethylamine N oxide-sparing choline carriers (citicoline, α glycerophosphocholine), together with LA restriction or alcohol abstinence, restore phosphatidylcholine/phosphatidylethanolamine balance, revive hepatic respiration and shrink intrahepatic fat. This dual nutrition-first approach targets the root bioenergetic defect, offering a low-risk route to halt steatosis progression and warrants large, randomized trials. |
| Publish Date |
2025-12-04 06:40 |
| Citation |
Mercola J. Fatty liver reexamined choline and mitochondrial toxin amelioration. World J Biol Chem 2025; 16(4): 111831 |
| URL |
https://www.wjgnet.com/1949-8454/full/v16/i4/111831.htm |
| DOI |
https://dx.doi.org/10.4331/wjbc.v16.i4.111831 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
